A patient with axial spondylarthritis who experienced pancytopenia while receiving anti-TNF therapy
Clinical Rheumatology, cilt.43, sa.8, ss.2701-2705, 2024 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Derleme
- Cilt numarası: 43 Sayı: 8
- Basım Tarihi: 2024
- Doi Numarası: 10.1007/s10067-024-07054-8
- Dergi Adı: Clinical Rheumatology
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.2701-2705
- Anahtar Kelimeler: Anti-TNF, Aplastic anemia, Etanercept, Thrombocytopenia
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Aplastic anemia is a rare and heterogeneous disease that causes pancytopenia and aplasia of the bone marrow. It is characterized by a failure of hematopoiesis. It is believed that approximately 65% of cases of acquired aplastic anemia are idiopathic. In a subset of cases, a drug or infection is the cause of bone marrow failure. This case report presents a 38-year-old patient with axial spondylarthritis who developed pancytopenia and was diagnosed with aplastic anemia during anti-TNF-α treatment.